✦ LIBER ✦

PMD29 PATIENT TIME AND INDIRECT COSTS ASSOCIATED WITH SENSOR-AUGMENTED INSULIN PUMP THERAPY IN TYPE 1 DIABETES

✍ Scribed by S. Kamble; K.P. Weinfurt; B.M. Perry; K.A. Schulman; S.D. Reed

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Sensor-Augmented P

✍ Shital Kamble; Kevin A. Schulman; Shelby D. Reed 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

PMD18 THE COST-EFFECTIVENESS OF INITIATI

✍ S. Kamble; B.M. Perry; J. Shafiroff; K.A. Schulman; S.D. Reed 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Benefits, risks, costs, and patient sati

✍ Steven G Gabbe; Emily Holing; Patricia Temple; Zane A Brown 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Sensor-Augmented Pump Therapy in Very Yo

✍ Frontino, Giulio; Bonfanti, Riccardo; Scaramuzza, Andrea; Rabbone, Ivana; Meschi 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 119 KB

Effectiveness of sensor-augmented pump t

✍ Robert H. Slover; John B. Welsh; Amy Criego; Stuart A. Weinzimer; Steven M. Will 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

Optimizing Insulin Therapy in Patients W

✍ Allison J. Hahr; Mark E. Molitch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 264 KB